Ketogenic and Low-Carbohydrate Diets in Prostate Cancer: Metabolic Rationale, Preclinical Evidence, and Preliminary Clinical Data

This study evaluates the role of ketogenic diets (KD) in prostate cancer (PCa) management, emphasizing its interaction with hormonal therapies and underlying metabolic mechanisms. Preclinical studies show KD can slow tumor growth and modulate oncogenic pathways, with emerging evidence suggesting synergistic effects when combined with standard therapies. Source: https://www.mdpi.com/2077-0383/15/10/3456